Anthony C Ike
Overview
Explore the profile of Anthony C Ike including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
106
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Okeke K, Ahamefule C, Nnabuife O, Orabueze I, Iroegbu C, Egbe K, et al.
Curr Res Microb Sci
. 2024 Nov;
7:100293.
PMID: 39497935
Notably, severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS) and coronavirus disease 2019 (COVID-19) have all had significant negative impact on global health and economy. COVID-19 alone, has...
2.
Orabueze I, Ike A, Aniche O, Nwafia I, Ebede S
BMC Public Health
. 2024 May;
24(1):1203.
PMID: 38724938
Introduction: Hepatitis B virus infection poses a global health challenge, particularly in low- and middle-income African countries. Illicit drug use exacerbates the problem, with drug users having a higher HBV...
3.
Ahamefule C, Ahamefule B, Ike A, Ogbonna J, Moneke A
Curr Microbiol
. 2023 Feb;
80(4):105.
PMID: 36790616
The application of Caenorhabditis elegans as a pathogenic model has spanned decades. Its use for pathogenic mould modeling has been attracting some attention lately, though not without some reservations. Several...
4.
Ahamefule C, Ezeuduji B, Ogbonna J, Moneke A, Ike A, Jin C, et al.
Front Cell Infect Microbiol
. 2021 Nov;
11:751947.
PMID: 34722339
The threat burden from pathogenic fungi is universal and increasing with alarming high mortality and morbidity rates from invasive fungal infections. Understanding the virulence factors of these fungi, screening effective...
5.
Ike A, Ononugbo C, Obi O, Onu C, Olovo C, Muo S, et al.
Vaccines (Basel)
. 2021 Jan;
9(1).
PMID: 33406695
Infectious bronchitis (IB) and Newcastle disease (ND) are two important diseases of poultry and have remained a threat to the development of the poultry industry in many parts of the...
6.
Reward E, Ike A, Muo S, Soga-Oke B, Mbaawuaga E
AIDS Rev
. 2020 Dec;
23(2):82-90.
PMID: 33258865
Tuberculosis (TB) and HIV/AIDS are major public health issues globally. The burden of these diseases is particularly significant in Nigeria due to the high TB and HIV/AIDS prevalence. This meta-analysis...
7.
Ahamefule C, Ezeuduji B, Ogbonna J, Moneke A, Ike A, Wang B, et al.
Antibiotics (Basel)
. 2020 Nov;
9(11).
PMID: 33207554
With the mortality rate of invasive aspergillosis caused by reaching almost 100% among some groups of patients, and with the rapidly increasing resistance of to available antifungal drugs, new antifungal...
8.
Ike A, Onu C, Ononugbo C, Reward E, Muo S
Vaccines (Basel)
. 2020 Jun;
8(2).
PMID: 32545507
Herpes simplex virus (HSV) infections are among the most common viral infections and usually last for a lifetime. The virus can potentially be controlled with vaccines since humans are the...
9.
Reward E, Muo S, Orabueze I, Ike A
Pathog Glob Health
. 2019 Oct;
113(5):229-237.
PMID: 31645218
A source of comprehensive information on the prevalence of herpes simplex virus type 1 and 2 (HSV-1 and HSV-2) can help researchers and policymakers address HSV related burden in the...
10.
Nazir J, Haumacher R, Ike A, Marschang R
Appl Environ Microbiol
. 2011 May;
77(14):4981-5.
PMID: 21622783
The persistence of 3 low-pathogenicity avian influenza viruses (LPAIV) (H4N6, H5N1, and H6N8) and one human influenza virus (H1N1) as well as Newcastle disease virus (NDV) and enteric cytopathogenic bovine...